ADB Cuts Developing Asia GDP Outlook as Recovery Paths Split
Growth paths in developing Asia continue to diverge, as some nations struggle with waves of infections while those that quickly rolled out vaccines and contained outbreaks gain from stronger global demand, according to the Asian Development Bank.
The region’s gross domestic product will expand 7.1% this year, down from 7.3% forecast in April and a turnaround from last year’s 0.1% contraction, the ADB said in its Asian Development Outlook Update released Wednesday. It sees developing Asia’s growth moderating to 5.4% in 2022.
“Developing Asia remains vulnerable to the Covid-19 pandemic,” Joseph Zveglich, acting chief economist at ADB, said in an accompanying statement. “New variants spark outbreaks, leading to renewed restrictions on mobility in some economies.”
The region’s recovery path is uneven, with East Asia’s exports helped by a surge in global demand, the Manila-based ADB said. Growth projections for China, the region’s largest economy, remain at 8.1% in 2021 and 5.5% next year. This year’s outlooks for Hong Kong, South Korea and Taiwan were raised.
Details: ADB Cuts Developing Asia 2021 GDP Forecast to 7.1%
Meanwhile, the forecast for Southeast Asia was lowered to 3.1% from 4.4% amid reduced projections for Indonesia, Malaysia, Thailand and Vietnam. The growth estimate this year for India was cut to 10% from 11%. Central Asia will grow 4.1% this year, up from 3.4%.
“The uneven progress of vaccinations is contributing to the divergence of growth paths,” the ADB said. Some economies that quickly rolled out vaccines and contained outbreaks have avoided tougher restrictions, allowing them to capitalize on improving global demand, it said.
“Policy measures should not only focus on containment and vaccination, but also on continuing support to firms and households and reorienting sectors,” Zveglich said.
Other highlights from the report:
- Inflation remains benign but will pick up in some economies. Regional inflation is forecast at 2.2% this year before accelerating to 2.7% in 2022
- A resurgence in outbreaks remains the main risk. But policy makers must also pay heed to other risks, including climate change, geopolitics and tightening financial conditions
©2021 Bloomberg L.P.